Clinical Trials Logo

Procedural Anxiety clinical trials

View clinical trials related to Procedural Anxiety.

Filter by:

NCT ID: NCT03628989 Completed - Pain Clinical Trials

Technology-Based Distractions During Minor Procedures

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset, Augmented Reality Headset) are more effective than the standard of care (i.e., no technology-based distraction) for decreasing anxiety and pain scores in pediatric patients undergoing various minor procedures (i.e lumbar punctures and cardiac catheterization). The anticipated primary outcome will be a reduction of overall cumulative medication and secondary outcomes include but are not limited to: physician satisfaction, discharge time, pain scores, anxiety scores, and procedure time.

NCT ID: NCT03475901 Completed - Procedural Anxiety Clinical Trials

Virtual Reality for Anxiolysis During Laceration Repair in the Pediatric Emergency Room

Start date: April 15, 2018
Phase: N/A
Study type: Interventional

The investigators propose a pilot study to examine the feasibility of utilizing immersive virtual reality to reduce procedural anxiety in children undergoing non-facial laceration repair in the Pediatric Emergency Department. The investigators hypothesize that virtual reality will be well-received by patients and their caregivers, and that the anxiety provoked by laceration repair will be mitigated by the immersive virtual reality experience.

NCT ID: NCT03399838 Withdrawn - Emergencies Clinical Trials

Comparing in Dexmedetomidine With po/pr Midazolam for Procedural Sedation in the Pediatric Emergency Department

PedINDEX
Start date: August 2023
Phase: Phase 4
Study type: Interventional

This study aims to compare efficacy of Procedural Sedation with Dexmedetomidine as compared to Midazolam in the pediatric Emergency Department. 210 children aged 6 months to 6 years will be included and randomly assigned to receiving oral or rectal midazolam (standard of care) or intranasal dexmedetomidine for procedures at the emergency department where mainly a sedation and no analgesia is sought. The procedure will be videotaped and analysis is blinded to the medication.

NCT ID: NCT03043430 Terminated - Anxiety Clinical Trials

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Start date: May 2016
Phase: Phase 4
Study type: Interventional

Investigators plan to conduct a randomized, double-blinded, controlled study among pediatric patients requiring minor procedures in the Emergency Department setting. Patients will be randomized to one of two arms of intranasal treatments: ketamine 1.0 mg/kg (K) or midazolam 0.3 mg/kg (M). The primary outcome will be change in anxiety using the Modified Yale Preoperative Anxiety Scale (mYPAS).